195 related articles for article (PubMed ID: 19728028)
1. Clinicopathological study on peripheral T-cell non-Hodgkin lymphoma with bone marrow involvement: a retrospective analysis from China.
Tong H; Ren Y; Qian W; Xiao F; Mai W; Meng H; Jin J
Int J Hematol; 2009 Oct; 90(3):303-310. PubMed ID: 19728028
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of T-cell lymphoma associated with hemophagocytic syndrome: comparison of T-cell lymphoma with and without hemophagocytic syndrome.
Tong H; Ren Y; Liu H; Xiao F; Mai W; Meng H; Qian W; Huang J; Mao L; Tong Y; Wang L; Qian J; Jin J
Leuk Lymphoma; 2008 Jan; 49(1):81-7. PubMed ID: 18203016
[TBL] [Abstract][Full Text] [Related]
3. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.
Schmitz N; Trümper L; Ziepert M; Nickelsen M; Ho AD; Metzner B; Peter N; Loeffler M; Rosenwald A; Pfreundschuh M
Blood; 2010 Nov; 116(18):3418-25. PubMed ID: 20660290
[TBL] [Abstract][Full Text] [Related]
5. [Clinical outcomes of different regimens for non-Hodgkin's lymphoma with bone marrow involvement: analysis of 148 cases].
Li QC; Yuan XL; Wang YF; Zou DH; Zhao YZ; Qiu LG
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):254-7. PubMed ID: 18361837
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of the efficiency of CHOP-based regimen with or without high dose consolidation treatment combined with hematopoietic stem cell transplantation in 63 lymphoblastic lymphoma patients].
Qin Y; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang JL; Yang S; Zhang CG; Dong M; Zhou LQ; Wang JW; Feng FY; Sun Y
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):469-73. PubMed ID: 19950562
[TBL] [Abstract][Full Text] [Related]
7. Comparison of long-term clinical outcomes of CHOP chemotherapy between Japanese patients with nodal peripheral T-cell lymphomas and those with diffuse large B-cell lymphoma in the study group of the Tohoku Hematology Forum.
Akagi T; Takahashi N; Yamaguchi K; Ishizawa K; Murai K; Tajima K; Ikeda K; Kameoka Y; Kameoka J; Ito S; Kato Y; Noji H; Shichishima T; Itoh J; Ichinohasama R; Harigae H; Ishida Y; Sawada K
J Clin Exp Hematop; 2011; 51(1):29-35. PubMed ID: 21628858
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma.
Xie W; Hu K; Xu F; Zhou D; He J; Shi J; Luo Y; Zhu J; Zhang J; Lin M; Ye X; Huang H; Cai Z
Ann Hematol; 2013 Apr; 92(4):481-6. PubMed ID: 23238896
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics and prognosis of patients with peripheral T-cell lymphoma.
Liang X; Guo L; Hu X; Li S; Wen S
Medicine (Baltimore); 2021 Apr; 100(13):e25194. PubMed ID: 33787601
[TBL] [Abstract][Full Text] [Related]
10. Clinical features and treatment of natural killer/T cell lymphoma associated with hemophagocytic syndrome: comparison with other T cell lymphoma associated with hemophagocytic syndrome.
Han L; Li L; Wu J; Li X; Zhang L; Wang X; Fu X; Ma W; Sun Z; Zhang X; Chang Y; Guo S; Zhang M
Leuk Lymphoma; 2014 Sep; 55(9):2048-55. PubMed ID: 24359240
[TBL] [Abstract][Full Text] [Related]
11. Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect of L-asparaginase based regimen, and prognostic factors.
Yong W; Zheng W; Zhu J; Zhang Y; Wei Y; Wang X; Lin N; Xie Y; Xu B; Li J
Hematol Oncol; 2006 Mar; 24(1):28-32. PubMed ID: 16323259
[TBL] [Abstract][Full Text] [Related]
12. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z
Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
14. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
16. An effective diagnostic index for lymphoma-associated hemophagocytic syndrome.
Xie M; Li L; Zhu L; Zhou D; Yang X; Sun J; Zhu J; Zhu M; Zheng Y; Xie W; Ye X
QJM; 2018 Aug; 111(8):541-547. PubMed ID: 29800321
[TBL] [Abstract][Full Text] [Related]
17. PEG-L-CHOP treatment is safe and effective in adult extranodal NK/T-cell lymphoma with a low rate of clinical hypersensitivity.
Zheng W; Gao Y; Ke X; Zhang W; Su L; Ren H; Lin N; Xie Y; Tu M; Liu W; Ping L; Ying Z; Zhang C; Deng L; Wang X; Song Y; Zhu J
BMC Cancer; 2018 Sep; 18(1):910. PubMed ID: 30241515
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
19. [Primary subcutaneous panniculitis-like T-cell cutaneous lymphoma: clinical presentation, treatment and prognosis].
Lü Z; Shi YK; Zhou LQ; Qin Y; Dong M; Yang JL; Liu P; Zhang CG
Zhonghua Zhong Liu Za Zhi; 2010 May; 32(5):350-3. PubMed ID: 20723432
[TBL] [Abstract][Full Text] [Related]
20. [Retrospective analyses of CHOPE plus L-asparaginase regimen in treatment of T-cell lymphoma].
Wan WL; Wang J; Zhu MX; Zhang W; Ke XY
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):841-845. PubMed ID: 27752167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
